Researchers from Mount Sinai Health System, Memorial Sloan Kettering Cancer Center, Nationwide Children’s Hospital/The Ohio State University, New York University Langone Medical Center, Weill Cornell Medicine, and Technion Israel Institute of Technology in Haifa, Israel, have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children. To target their drug-loaded nanoparticles to the site of the disease – and not the normal brain regions – the researchers used a normal mechanism that the immune system uses to traffic white blood cells to sites of infection, inflammation, or tissue injury.
An official website of the United States government.